Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Myung-Hee Chung is active.

Publication


Featured researches published by Myung-Hee Chung.


The FASEB Journal | 2005

STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells

Joo Eun Jung; Hyun Gyu Lee; Ik Hyun Cho; Doo Hyun Chung; Sun-Hee Yoon; Young Mok Yang; Jung Weon Lee; Seongwon Choi; Jong-Wan Park; Sang-Kyu Ye; Myung-Hee Chung

Aberrantly enhanced vascular endothelial growth factor (VEGF) gene expression is associated with increased tumor growth and metastatic spread of solid malignancies, including human renal carcinomas. Persistent activation of STAT3 is linked to tumor‐associated angiogenesis, but underlying mechanisms remain unclear. Therefore, we examined whether STAT3 modulates the stability and activity of hypoxia‐inducible factor‐1α (HIF‐1α), and in turn enhances VEGF expression. We found that STAT3 was activated in ischemic rat kidneys and hypoxic human renal carcinoma cells. We also found that hypoxia‐induced activation of STAT3 transactivated the VEGF promoter and increased the expression of VEGF transcripts. Consistent with these findings, STAT3 inhibition attenuated the hypoxic induction of VEGF. Interestingly, activated STAT3 increased HIF‐1α protein levels due to the HIF‐1α stability by blocking HIF‐1α degradation and accelerated its de novo synthesis. The novel interaction of STAT3 with HIF‐1α was identified in hypoxic renal carcinoma cells. Furthermore, hypoxia recruited STAT3, HIF‐1α, and p300 to the VEGF promoter and induced histone H3 acetylation. Therefore, these findings provide compelling evidence that a causal relationship exists between STAT3 activation and HIF‐1‐dependent angiogenesis and suggest that therapeutic modalities designed to disrupt STAT3 signaling hold considerable promise for the blocking tumor growth and enhancing apoptosis of cancer cells and tissues.


Seminars in Integrative Medicine | 2003

A review on the relationship between aloe vera components and their biologic effects

Seongwon Choi; Myung-Hee Chung

Abstract Aloe vera (Aloe barbadensis Miller) is a perennial succulent belonging to the Liliaceal family, and is called the healing plant or the silent healer. As a result of its use as folk medicine, it is claimed that aloe vera has wound and burn healing properties, and antiinflammatory, and immunomodulatory effects. Aloe vera is used in a variety of commercial products because of these therapeutic properties. It is being used as a whole extract, however, and the relationship between the components of the extract and its overall effect has not been clarified. A more precise understanding of the biologic activities of these is required to develop aloe vera as a pharmaceutical source. Many attempts have been made to isolate single, biologically active components, to examine their effects, and clarify their functional mechanism. This review focuses on the relationship between the isolated aloe vera components (ie, glycoproteins, anthraquinones, saccharides, low-molecular-weight substances) and their presumed pharmacologic activities.


British Journal of Dermatology | 2001

The wound-healing effect of a glycoprotein fraction isolated from aloe vera

Seongwon Choi; Son Bw; Son Ys; Young-In Park; Seung-Ki Lee; Myung-Hee Chung

Background Aloe vera has been used as a family medicine for promoting wound healing, but it is not known which component of the plant is effective for this purpose.


Free Radical Biology and Medicine | 1994

DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria

Hunjoo Ha; Chul Koo Kim; Youngsook Son; Myung-Hee Chung; Kyung Hwan Kim

8-Hydroxydeoxyguanosine (8-OHdG), an oxygen radical induced modification of purine residue in DNA, was measured in the liver, pancreas, and kidney of streptozotocin-induced diabetic rats (STZR) exhibiting microalbuminuria. At 4 weeks after the injection of streptozotocin (50 mg/kg, i.v.), the rate of urinary albumin excretion was 0.5 +/- 0.1 and 2.0 +/- 0.2 mg/24 h in age-matched control rats (CR) and STZR, respectively. Compared to CR, STZR also showed a significantly increased level of 8-OHdG in the kidney but not the liver and pancreas. Amounts of 8-OHdG/10(5) dG for CR and STZR were 3.4 +/- 0.3 and 5.1 +/- 0.2 for renal cortices, and 4.1 +/- 0.2 and 20.0 +/- 3.7 for renal papillae. Daily injection of insulin (2 U, SC) starting on the third day after streptozotocin treatment significantly reduced both urinary albumin excretion and papillary 8-OHdG formation, which suggests that these are associated with the diabetic state induced by streptozotocin rather than a direct nephrotoxic effect of the drug. This study suggests that formation of 8-OHdG and, therefore, oxidative damage are closely related in the process of diabetic nephropathy.


Angiogenesis | 1999

A novel angiogenic factor derived from Aloe vera gel: beta-sitosterol, a plant sterol.

Eun-Joung Moon; You Mie Lee; Ok-Hee Lee; Myoung-Jin Lee; Seung-Ki Lee; Myung-Hee Chung; Young-In Park; Chung-Ki Sung; Jae-Soo Choi; Kyu-Won Kim

Aloe vera gel has a beneficial effect on wound healing. Because angiogenesis is an essential process in wound healing, we hypothesized that Aloe vera gel might contain potent angiogenic compounds. Here we demonstrate that Aloe vera gel and its extracts are angiogenic on the chorioallantoic membrane (CAM) of chick embryo. Out of the three compounds purified from the final fraction of Aloe vera gel, β-sitosterol showed a potent angiogenic activity in the CAM assay. In the presence of heparin, β-sitosterol stimulated neovascularization in the mouse Matrigel plug assay and the motility of human umbilical vein endothelial cells in an in vitro wound migration assay. Thus β-sitosterol is a novel plant-derived angiogenic factor which may have potential pharmaceutical applications for the management of chronic wounds.


Cancer Research | 2004

Oncogenic H-Ras Up-Regulates Expression of ERCC1 to Protect Cells from Platinum-Based Anticancer Agents

Cha-Kyung Youn; Mi-Hwa Kim; Hyun-Ju Cho; Hong-Beum Kim; In-Youb Chang; Myung-Hee Chung; Ho Jin You

Tumors frequently contain mutations in the ras genes, resulting in the constitutive activation of the Ras-activated signaling pathway. The activation of Ras is involved not only in tumor progression but also in the development of resistance of the tumor cells to platinum-based chemotherapeutic agents. To investigate the potential mechanisms underlying this resistance, we analyzed the effect of activated H-Ras on the expression of the nucleotide excision repair genes. Here we identified ERCC1, which is one of the key enzymes involved in nucleotide excision repair, as being markedly up-regulated by the activated H-Ras. From promoter analysis of ERCC1, an increase in the Ap1 transcriptional activity as a result of the expression of the oncogenic H-Ras was found to be crucial for this induction. In addition, ERCC1 small interfering RNA expression was shown to reduce the oncogenic H-Ras-mediated increase in the DNA repair activity as well as to suppress the oncogenic H-Ras-mediated resistance of the cells to platinum-containing chemotherapeutic agents. These results suggest that the oncogenic H-Ras-induced ERCC1, which activates the DNA repair capacity, may be involved in the protection of the cells against platinum-based anticancer agents.


Nature Cell Biology | 2005

Bcl-2 expression suppresses mismatch repair activity through inhibition of E2F transcriptional activity.

Cha-Kyung Youn; Hyun-Ju Cho; Soo-Hyun Kim; Hong-Beum Kim; Mi-Hwa Kim; In-Youb Chang; Jung-Sup Lee; Myung-Hee Chung; Kyung-Soo Hahm; Ho Jin You

Bcl-2 stimulates mutagenesis after the exposure of cells to DNA-damaging agents. However, the biological mechanisms of Bcl-2-mediated mutagenesis have remained largely obscure. Here we demonstrate that the Bcl-2-mediated suppression of hMSH2 expression results in a reduced cellular capacity to repair mismatches. The pathway linking Bcl-2 expression to the suppression of mismatch repair (MMR) activity involves the hypophosphorylation of pRb, and then the enhancement of the E2F–pRb complex. This is followed by a decrease in hMSH2 expression. MMR has a key role in protection against deleterious mutation accumulation and in maintaining genomic stability. Therefore, the decreased MMR activity by Bcl-2 may be an underlying mechanism for Bcl-2-promoted oncogenesis.


Free Radical Biology and Medicine | 2008

Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia

Hong Sook Kim; Ik Hyun Cho; Ja-Eun Kim; Yong Jae Shin; Ju-Hong Jeon; Youngsoo Kim; Young Mok Yang; Kwang Ho Lee; Jung Weon Lee; Wang-Jae Lee; Sang-Kyu Ye; Myung-Hee Chung

Ethyl pyruvate (EP) has been demonstrated to have an anti-inflammatory function. However, the molecular mechanisms underlying the anti-inflammatory action of EP are largely unknown. We here show that EP exerts its anti-inflammatory effect by inhibiting ROS-dependent STAT signaling through its antioxidant activity, like vitamin C or N-acetyl-L-cysteine. The inhibition of STAT1 and STAT3 by EP prevented their translocation to the nucleus and consequently inhibited expression of iNOS and COX-2 by inhibiting STAT1- and STAT3-mediated transcriptional activity, followed by changes in chromatin conformation via deacetylation of histones H3 and H4 in both gene promoters. EP also suppressed transcripts of other STAT-responsive inflammatory genes such as IL-1beta, IL-6, TNF-alpha, and MCP-1. We further found that the mechanism of inhibition of STAT1 and STAT3 by EP is due to inhibition of JAK2 through Rac1 inactivation and SOCS1 induction. These findings offer new therapeutic possibilities for EP based on a better understanding of the mechanism underlying the action of EP.


Experimental and Molecular Medicine | 2008

STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination

Joo Eun Jung; Hong Sook Kim; Chang Seok Lee; Yong-Jae Shin; Yong-Nyun Kim; Gyeong-Hoon Kang; Tae-You Kim; Yong-Sung Juhnn; Sung Joon Kim; Jong-Wan Park; Sang-Kyu Ye; Myung-Hee Chung

Hypoxia-inducible factor 1α (HIF-1α) is rapidly degraded by the ubiquitin-proteasome pathway under normoxic conditions. Ubiquitination of HIF-1α is mediated by interaction with von Hippel-Lindau tumor suppressor protein (pVHL). In our previous report, we found that hypoxia-induced active signal transducer and activator of transcription3 (STAT3) accelerated the accumulation of HIF-1α protein and prolonged its half-life in solid tumor cells. However, its specific mechanisms are not fully understood. Thus, we examined the role of STAT3 in the mechanism of pVHL-mediated HIF-1α stability. We found that STAT3 interacts with C-terminal domain of HIF-1α and stabilizes HIF-1α by inhibition of pVHL binding to HIF-1α. The binding between HIF-1α and pVHL, negative regulator of HIF-1α stability, was interfered dose-dependently by overexpressed constitutive active STAT3. Moreover, we found that the enhanced HIF-1α protein levels by active STAT3 are due to decrease of poly-ubiquitination of HIF-1α protein via inhibition of interaction between pVHL and HIF-1α. Taken together, our results suggest that STAT3 decreases the pVHL-mediated ubiquitination of HIF-1α through competition with pVHL for binding to HIF-1α, and then stabilizes HIF-1α protein levels.


Oncogene | 2010

The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage

Jun Haeng Lee; Y. Kang; V. Khare; Z.-Y. Jin; M.-Y. Kang; Y. Yoon; Jin-Won Hyun; Myung-Hee Chung; S.-I. Cho; J. Y. Jun; I.-Y. Chang; H. J. You

The p53-inducible gene 3 (PIG3) is originally isolated as a p53 downstream target gene, but its function remains unknown. Here, we report a role of PIG3 in the activation of DNA damage checkpoints, after UV irradiation or radiomimetic drug neocarzinostatin (NCS). We show that depletion of endogenous PIG3 sensitizes cells to DNA damage agents, and impaired DNA repair. PIG3 depletion also allows for UV- and NCS-resistant DNA synthesis and permits cells to progress into mitosis, indicating that PIG3 knockdown can suppress intra-S phase and G2/M checkpoints. PIG3-depleted cells show reduced Chk1 and Chk2 phosphorylation after DNA damage, which may directly contribute to checkpoint bypass. PIG3 exhibited diffuse nuclear staining in the majority of untreated cells and forms discrete nuclear foci in response to DNA damage. PIG3 colocalizes with γ-H2AX and 53BP1 to sites of DNA damage after DNA damage, and binds to a γ-H2AX. Notably, PIG3 depletion decreases the efficient induction and maintenance of H2AX phosphorylation after DNA damage. Moreover, PIG3 contributes to the recruitment of 53BP1, Mre11, Rad50 and Nbs1 to the sites of DNA break lesions in response to DNA damage. Our combined results suggest that PIG3 is a critical component of the DNA damage response pathway and has a direct role in the transmission of the DNA damage signal from damaged DNA to the intra-S and G2/M checkpoint machinery in human cells.

Collaboration


Dive into the Myung-Hee Chung's collaboration.

Top Co-Authors

Avatar

Sang-Kyu Ye

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Seongwon Choi

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Jin-Won Hyun

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Chang Seok Lee

Seoul National University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ja-Eun Kim

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Sun-Hee Yoon

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Hong Sook Kim

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Jeong-Yun Choi

Seoul National University

View shared research outputs
Top Co-Authors

Avatar

Jong-Wan Park

Seoul National University

View shared research outputs
Researchain Logo
Decentralizing Knowledge